Showing results (491-500 of 2,397) with videos related to

Sort By:
Pageof 240
Translational Lung Cancer Research|January 11, 2024
Does subtyping of high-grade pulmonary neuroendocrine carcinomas have an impact on therapy selection?Helmut Popper, Luka Brcic, Sylvia Eidenhammer
Translational Lung Cancer Research|January 11, 2024
Tract creation with a 25-gauge needle for convex endobronchial ultrasound-guided core biopsy in intrapulmonary lesions adjacent to bronchi: three case reportsHiroaki Nagamine, Toshiyuki Nakai, Takahiro Ueda, et al.
Translational Lung Cancer Research|December 13, 2023
Seven preoperative factors have strong predictive value for postoperative pneumonia in patients undergoing thoracoscopic lung cancer surgeryHongliang Bian, Minghui Liu, Jinghao Liu, et al.
Translational Lung Cancer Research|December 13, 2023
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort studyDongming Zhang, Xiaoyan Liu, Fangfang Shen, et al.
Translational Lung Cancer Research|December 13, 2023
Long-term survival after stereotactic body radiotherapy combined with immunotherapy plus anti-angiogenesis therapy in patients with advanced non-small cell lung cancer and EGFR exon 20 insertion mutation: a report of two casesQiang Luo, Leichong Chen, Zhenyu Li, et al.
Translational Lung Cancer Research|December 13, 2023
Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case reportBowen Li, Ziqi Jia, Zhicheng Huang, et al.
Translational Lung Cancer Research|November 29, 2023
Safety and efficacy of thoracic radiotherapy combined with chemo-immunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysisZijing Cai, Xiaoling Gu, Jingyuan Xie, et al.
Translational Lung Cancer Research|March 18, 2024
HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitorsMeejeong Kim, Hyun-Min Ju, Ji-Young Song, et al.
Translational Lung Cancer Research|March 18, 2024
Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analysesSehhoon Park, Jun-Kyu Kang, Naeun Lee, et al.
Translational Lung Cancer Research|March 18, 2024
Osimertinib in uncommon EGFR exon 21 L861R and EGFR exon 18 deletion-insertion mutant non-small cell lung cancer-case reportYang Wang, Pranav Dorwal, Suraindra Rajadurai, et al.
Pageof 240